Epitalon (Epithalon)
Epitalon is a synthetic four-amino-acid peptide studied primarily in Russia. Research focuses on activating telomerase (an enzyme that maintains chromosome caps), supporting pineal gland function, and potential anti-aging effects.
Verified sources for Epitalon (Epithalon)
These vendors are vetted by PeptideWiki for purity testing and COA transparency.
Overview of Epitalon (Epithalon)
May influence telomerase activity and melatonin production through neuroendocrine pathways, potentially supporting cellular longevity.
Proposed to increase telomerase activity in somatic cells (proposed), which may extend telomere length and cellular replicative capacity.
May influence expression of antioxidant enzyme genes (proposed), with potential reduction in oxidative stress markers.
May influence pineal gland function and melatonin synthesis (proposed), particularly in aged subjects where pineal activity diminishes.
Proposed to restore normal melatonin secretion patterns, which may improve circadian rhythm regulation and sleep quality.
Acts on hypothalamic-pituitary signaling (proposed), influencing multiple downstream hormonal systems
Read Full Epitalon (Epithalon) Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Longevity & Cellular Health
UPDATE: FDA Picks 7 Peptides for July 2026 Reclassification Vote
The FDA will vote on reclassifying BPC-157, TB-500, KPV, MOTS-c, DSIP, Epitalon, and Semax for pharmacy compounding at the July 23-24 PCAC meeting.
Peptide Therapy for Sleep Optimization: The Quiet Trend Reshaping Recovery in 2026
Peptide therapy is quietly becoming the most promising frontier in sleep science. From DSIP to growth hormone secretagogues, here's how peptides are being studied for deep sleep and recovery.
Clinical Trials for Peptide Drugs Are Surging: Why the Pipeline Is Exploding in 2026
Peptide clinical trials have surged dramatically, with over 150 peptides now in active trials and 400+ in preclinical development. Here's why peptides are becoming the dominant drug class and what it means for the future of medicine.
RFK Jr. Says 14 Peptides Are Coming Back: Ban Reversal
HHS Secretary RFK Jr. told Joe Rogan that ~14 peptides banned by the FDA in 2023 will return to Category 1, restoring legal compounding access.